Memory formation

Memory formation — also called memory encoding — is the multi-stage process by which an experience becomes a durable neural record. The hippocampus, a seahorse-shaped structure deep in the medial temporal lobe, is the central hub: it binds sensory details, context, and emotional tone from disparate brain regions into a coherent episode.

The process unfolds in overlapping stages. Encoding converts incoming experience into a neural pattern. Consolidation stabilises that pattern over hours to years, partly during sleep, when the hippocampus replays recent events to the cortex for longer-term storage. Retrieval later reactivates the trace — a reconstructive act, not a playback.

Not all memory depends on the hippocampus equally. Episodic memory (personal events) and semantic memory (facts) rely on it heavily; procedural memory (skills, habits) uses the basal ganglia and cerebellum instead. This is why certain substances can suppress event memory while leaving a person able to walk, talk, and follow a conversation — the gap becomes apparent only afterwards.

How it works · its role

The cellular engine of memory formation is long-term potentiation (LTP): repeated co-firing of neurons strengthens the synapse between them, making future co-activation easier. NMDA-type glutamate receptors are the gatekeepers of this process — they open only when the receiving neuron is already active, effectively detecting coincidence and marking the moment as worth encoding.

Acetylcholine also plays a key role. Cholinergic projections from the basal forebrain modulate hippocampal activity and raise the signal-to-noise ratio during new learning. Noradrenaline and the amygdala amplify encoding of emotionally significant events, which is why vivid fear or intense pleasure tends to be remembered more reliably than neutral background detail.

Relevance to substances & effects

Several substance classes interfere with this system, and many share a common pattern: encoding is suppressed while general cognition remains intact enough that the gap is not obvious in the moment.

Alcohol and benzodiazepines potentiate GABA-A receptors and suppress NMDA signalling, both of which blunt LTP in the hippocampus. At sufficient doses this produces anterograde amnesia — a blackout — in which events during intoxication simply fail to be encoded, leaving no accessible trace. The person may act coherently throughout.

NMDA-receptor antagonists such as ketamine block the receptor directly, producing dissociative amnesia at sub-anaesthetic doses. Anticholinergic compounds — including scopolamine and some antihistamines — disrupt the cholinergic modulation that LTP depends on, impairing new learning without necessarily causing strong sedation.

Cannabis, via CB1-receptor activation in the hippocampus, impairs short-term memory consolidation, particularly at higher doses. This typically presents as difficulty holding the thread of a conversation rather than a full blackout, though repeated heavy exposure during adolescence is associated with longer-lasting encoding deficits.

Classic psychedelics and MDMA can heighten the emotional salience of an experience, which in theory strengthens encoding. At high doses, however, cognitive disorganisation and sensory overload may work against coherent consolidation of the event.